Cargando…

In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line

PURPOSE: Human papillomavirus (HPV) type 16 is one of the major etiologic factors of cervical cancer. Our study aims to investigate the potentiality of the antiviral clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated Cas9 system (CRISPR/Cas9) targeting the E6 and E7...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhen, Shuai, Lu, Jiao-Jiao, Wang, Li-Jie, Sun, Xiao-Min, Zhang, Jia-Qi, Li, Xu, Luo, Wen-Juan, Zhao, Le
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Neoplasia Press 2016
Materias:	Original article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094426/ https://www.ncbi.nlm.nih.gov/pubmed/27816686 http://dx.doi.org/10.1016/j.tranon.2016.10.002

Ejemplares similares

CRISPR/Cas9-mediated cervical cancer treatment targeting human papillomavirus E6
por: Yoshiba, Takahiro, et al.
Publicado: (2019)

Adenoviral Vectors Armed with PAPILLOMAVIRUs Oncogene Specific CRISPR/Cas9 Kill Human-Papillomavirus-Induced Cervical Cancer Cells
por: Ehrke-Schulz, Eric, et al.
Publicado: (2020)

Codelivery of CRISPR-Cas9 and chlorin e6 for spatially controlled tumor-specific gene editing with synergistic drug effects
por: Deng, Shaohui, et al.
Publicado: (2020)

Human Papillomavirus 16 E6 and E7 Synergistically Repress Innate Immune Gene Transcription
por: James, Claire D., et al.
Publicado: (2020)

Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system
por: Trakarnsanga, Kongtana, et al.
Publicado: (2022)

CRISPR/Cas9 nanoeditor of double knockout large fragments of E6 and E7 oncogenes for reversing drugs resistance in cervical cancer
por: Li, Xianhuang, et al.
Publicado: (2021)

Application of CRISPR/Cas9 in plant biology
por: Liu, Xuan, et al.
Publicado: (2017)

CRISPR-Cas9 In Situ engineering of subtilisin E in Bacillus subtilis
por: Price, Marcus A., et al.
Publicado: (2019)

Description of CRISPR-Cas9 development and its prospects in human papillomavirus-driven cancer treatment
por: Wei, Yuhao, et al.
Publicado: (2022)

Disruption of HPV16-E7 by CRISPR/Cas System Induces Apoptosis and Growth Inhibition in HPV16 Positive Human Cervical Cancer Cells
por: Hu, Zheng, et al.
Publicado: (2014)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

The application of CRISPR/Cas9 system in cervical carcinogenesis
por: Gao, Chun, et al.
Publicado: (2021)

Human papillomavirus 16E6/E7 activates autophagy via Atg9B and LAMP1 in cervical cancer cells
por: Tingting, Chen, et al.
Publicado: (2019)

Immunohistochemical Detection of Human Papillomavirus 16 E7 Oncoprotein in Cervical Lesions
por: Zhu, Jiang, et al.
Publicado: (2021)

Genetic diversity of E6, E7 and the long control region in human papillomavirus type 16 variants in Beijing, China
por: Wang, Jiao, et al.
Publicado: (2022)

Mobile CRISPR-Cas9 based anti-phage system in E. coli
por: Cao, Zhou, et al.
Publicado: (2022)

CRISPR/Cas9 for hepatitis B virus infection treatment
por: Cai, Bo, et al.
Publicado: (2023)

Establishment of CRISPR-Cas9 system in Bifidobacteria animalis AR668
por: Li, Jiao, et al.
Publicado: (2023)

E6/E7 Variants of Human Papillomavirus 16 Associated with Cervical Carcinoma in Women in Southern Mexico
por: Antaño-Arias, Ramón, et al.
Publicado: (2021)

Analysis of genetic variation in human papillomavirus type 16 E1 and E2 in women with cervical infection in Xinjiang, China
por: Wang, Luyue, et al.
Publicado: (2021)

Mimicking natural polymorphism in eIF4E by CRISPR‐Cas9 base editing is associated with resistance to potyviruses
por: Bastet, Anna, et al.
Publicado: (2019)

Simultaneously induced mutations in eIF4E genes by CRISPR/Cas9 enhance PVY resistance in tobacco
por: Le, Ngoc Thu, et al.
Publicado: (2022)

Efficient CRISPR/Cas9-mediated Targeted Mutagenesis in Populus in the First Generation
por: Fan, Di, et al.
Publicado: (2015)

The Cas6e ribonuclease is not required for interference and adaptation by the E. coli type I-E CRISPR-Cas system
por: Semenova, Ekaterina, et al.
Publicado: (2015)

Eradication of cervical cancer in vivo by an AAV vector that encodes shRNA targeting human papillomavirus type 16 E6/E7
por: Sato, Naoto, et al.
Publicado: (2018)

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells
por: Yu, Lan, et al.
Publicado: (2014)

E7-Targeted Nanotherapeutics for Key HPV Afflicted Cervical Lesions by Employing CRISPR/Cas9 and Poly (Beta-Amino Ester)
por: Xiong, Jinfeng, et al.
Publicado: (2021)

Efficient Generation of Myostatin Mutations in Pigs Using the CRISPR/Cas9 System
por: Wang, Kankan, et al.
Publicado: (2015)

Gene Expression Profiles are Altered in Human Papillomavirus-16 E6 D25E-Expressing Cell Lines
por: Jang, Mi, et al.
Publicado: (2011)

Increased expression of PD-L1 by the human papillomavirus 16 E7 oncoprotein inhibits anticancer immunity
por: Liu, Chaoqi, et al.
Publicado: (2017)

Human Papillomavirus Type 16 E1 Mutations Associated with Cervical Cancer in a Han Chinese Population
por: Yao, Yueting, et al.
Publicado: (2019)

What is CRISPR/Cas9?
por: Redman, Melody, et al.
Publicado: (2016)

Advances in CRISPR/Cas9
por: Zhu, Youmin
Publicado: (2022)

Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates
por: Boumba, Luc Magloire Anicet, et al.
Publicado: (2015)

Identification of Antibodies against Human Papillomavirus Type 16 E6 and E7 Proteins in Sera of Patients with Cervical Neoplasias
por: Sasagawa, Toshiyuki, et al.
Publicado: (1992)

High Levels of Within-Host Variations of Human Papillomavirus 16 E1/E2 Genes in Invasive Cervical Cancer
por: Hirose, Yusuke, et al.
Publicado: (2020)

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Corrigendum]
Publicado: (2015)

Disruption of human papillomavirus 16 E6 gene by clustered regularly interspaced short palindromic repeat/Cas system in human cervical cancer cells [Retraction]
Publicado: (2017)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

CRISPR/Cas9-Mediated Targeting of Susceptibility Factor eIF4E-Enhanced Resistance Against Potato Virus Y
por: Noureen, Azka, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jlraje29r6cu3md04f7clmjfcp